Back

The prognostic utility of troponin T levels in patients undergoing PCI during initial hospitalisation for STEMI

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Diagnostic and prognostic performance of cardiac troponin Biomarkers ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Mr Tharusha Ediriweera

(Australia)

8 More presentations in this session

Presentation thumbnail
Troponin T as a risk marker for recurrent cardiovascular events in the post-discharge setting one month after acute coronary syndrome: a TRACER substudy
Doctor C. Wassberg (Uppsala, SE)
Abstract Slides Video
Presentation thumbnail
High-sensitivity troponin T and risk of stroke in persons with suspected acute coronary syndrome
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial
Doctor K. Jering (Boston, US)
Abstract Slides Video
Presentation thumbnail
Performance of a 99th percentile multiplier troponin score to predict in-hospital events and 1 year mortality in acute coronary syndrome
Slides Video
Presentation thumbnail
Troponin elevation during infection is associated with increased acute and long-term mortality
Slides Video

Access the full session

Session thumbnail
Diagnostic and prognostic performance of cardiac troponin

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial
thumbnail
Congress Presentation
The prognostic value of normal troponin on admission in STEMI patients: an 8-year multicenter cohort
thumbnail
Congress Presentation
Troponin T as a risk marker for recurrent cardiovascular events in the post-discharge setting one month after acute coronary syndrome: a TRACER substudy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources